Bernstein Starts Biogen (BIIB) at Outperform
Tweet
Share
E-mail
Get Alerts BIIB Hot Sheet
Price: $206.28 -0.17%
Rating Summary:
27 Buy, 16 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 27 | Down: 45 | New: 5
Rating Summary:
27 Buy, 16 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 27 | Down: 45 | New: 5
Join SI Premium – FREE
Bernstein initiated coverage on Biogen (NASDAQ: BIIB) with an Outperform rating and a price target of $282.00.
For an analyst ratings summary and ratings history on Biogen click here. For more ratings news on Biogen click here.
Shares of Biogen closed at $224.60 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Stifel Starts Sutro Biopharma (STRO) at Buy
- BofA Securities Resumes SK Hynix (000660:KS) (SKHY) at Buy, 'appears undervalued vs super-cycle earnings'
- Canaccord Starts Tecsys Inc (TCS:CN) (TCYSF) at Buy
Create E-mail Alert Related Categories
Hot New Coverage, New CoverageRelated Entities
Sanford C. BernsteinSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
